The expression of ephrin-B1 is higher in bladder cancer tissues than normal urothelial tissue, suggesting that ephrin-B1 can be used as a biomarker of bladder cancer aggressiveness (Mencucci et al., 2020). This evidence concerns the gene EFNB1 and urinary bladder carcinoma.